|
Characteristic
|
Cases
|
Controls
|
P value
|
|---|
|
No.(%)
|
573 (100)
|
721 (100)
| |
|
Age, no.(%)
| | | |
|
15-49 y
|
179 (31.2)
|
201 (27.9)
| |
|
50-64 y
|
226 (39.4)
|
286 (39.7
| |
|
≥ 65 y
|
168 (29.3)
|
234 (32.5)
|
0.33
|
|
Mean(yr.) ± SD
|
55.0 ± 14.6
|
56.0 ± 15.3
| |
|
Range
|
15.0-90.0
|
17.0-82.5
| |
|
Sex
| | | |
|
Male
|
336 (58.6)
|
417 (57.8)
| |
|
Female
|
237 (41.4)
|
304 (42.2)
|
0.77
|
|
NHL tumor pathology
| | | |
|
All B-cell lymphoma
|
451
|
NA
|
NA
|
|
Diffuse large B-cell
|
330
|
NA
|
NA
|
|
Marginal zone*
|
69
|
NA
|
NA
|
|
Follicular
|
17
|
NA
|
NA
|
|
Mantle cell
|
12
|
NA
|
NA
|
|
Small lymphocytic
|
8
|
NA
|
NA
|
|
Burkitt lymphoma
|
3
|
NA
|
NA
|
|
OthersB
|
12
|
NA
|
NA
|
|
All T-cell lymphoma
|
122
|
NA
|
NA
|
|
Peripheral T-cell
|
55
|
NA
|
NA
|
|
OthersT
|
67
|
NA
|
NA
|
-
P values for differences in socio-demographic characteristics between cases and controls.
- NA indicates not applicable. Marginal zone* includes marginal zone B-cell lymphoma (n = 12) and mucosa-associated lymphoid tissue (MALT) (n = 57). OthersB includes B-cell prolymphocytic leukemia (n = 1) and undetermined B-cell lymphoma (n = 11). OthersT includes all T-cell lymphoma (n = 67) except for peripheral T-cell lymphoma.
